4.6 Article

CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

APOE ε4 dose associates with increased brain iron and β-amyloid via blood-brain barrier dysfunction

Yuto Uchida et al.

Summary: The study aimed to examine the effect of APOE ε4 dose on BBB clearance function and its correlation with brain iron and beta-amyloid accumulation. The results showed that increased APOE ε4 dose was associated with decreased effective brain-waste clearance through the BBB.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy

Abdel Ali Belaidi et al.

Summary: Allelic variation to the APOE gene is the greatest genetic risk for sporadic Alzheimer's disease. Recent studies have found a link between APOE gene and brain iron, potentially through the ferroptosis pathway, to explain disease progression. Researchers discovered that apoE acts as a potent inhibitor of ferroptosis through activation of the PI3K/AKT pathway. Another study revealed that the APOE-epsilon 4 allele is more strongly associated with iron-related Alzheimer's disease, possibly due to lower levels of apoE protein and higher levels of polyunsaturated fatty acids.

MOLECULAR PSYCHIATRY (2022)

Review Neurosciences

Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age

Scott Ayton et al.

Summary: The study analyzed APR proteins in the CSF of 1291 subjects and found that CSF Aβ(42)/t-tau status was associated with elevated levels of ferritin, while the increase in APR proteins was correlated with symptomatic progression, mediated by CSF p-tau181. Gender and age influenced the levels of APR proteins in CSF.

PROGRESS IN NEUROBIOLOGY (2021)

Article Clinical Neurology

Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance

Scott Ayton et al.

Summary: This paper proposes an updated version of the iron hypothesis in Alzheimer's disease, suggesting that brain iron levels are associated with disease progression and may play a role in neurodegeneration. Further research is needed to validate the hypothesis.

ALZHEIMERS & DEMENTIA (2021)

Article Geriatrics & Gerontology

Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain

Ryan K. Shahidehpour et al.

Summary: The study found an age-associated increase in dystrophic microglia in the hippocampus and frontal cortex, but this increase was proportional to the total number of microglia, suggesting aging alone does not explain the presence of dystrophic microglia. Dystrophic microglia, rather than hypertrophic microglia, were found to be the disease-associated microglia morphology. Furthermore, changes in iron homeostasis in dystrophic microglia were identified as a potential molecular mechanism driving the degeneration of microglia in neurodegenerative disease.

NEUROBIOLOGY OF AGING (2021)

Article Neurosciences

Iron loading is a prominent feature of activated microglia in Alzheimer's disease patients

Boyd Kenkhuis et al.

Summary: Brain iron accumulation accelerates disease progression in Alzheimer patients with amyloid-beta. Activated microglia with increased iron accumulation influence the functional phenotype of cells, especially in conjunction with amyloid-beta. Spatial analysis showed that iron-accumulating microglia predominantly infiltrated A beta-plaques in the brain.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Md. Jakaria et al.

Summary: Alzheimer's disease, the most prevalent form of dementia, has a complex pathophysiology that is not fully understood. While beta-amyloid plaque and neurofibrillary tangles define the disease's pathology, the mechanism of neurodegeneration remains uncertain. Ferroptosis, an iron-mediated programmed cell death mechanism, has been observed in clinical AD samples, suggesting its implication in the pathogenesis of AD.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Multidisciplinary Sciences

Biogenic metallic elements in the human brain?

James Everett et al.

Summary: The elemental forms of copper and iron in the brain have been discovered, leading to new questions about their role in neurochemistry and disease etiology.

SCIENCE ADVANCES (2021)

Article Biochemistry & Molecular Biology

Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology

Scott Ayton et al.

MOLECULAR PSYCHIATRY (2020)

Article Biochemistry & Molecular Biology

Iron potentiates microglial interleukin-1β secretion induced by amyloid-β

Israel C. Nnah et al.

JOURNAL OF NEUROCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Amyloidogenic processing of Alzheimer's disease β-amyloid precursor protein induces cellular iron retention

Andrew Tsatsanis et al.

MOLECULAR PSYCHIATRY (2020)

Article Clinical Neurology

The implications of different approaches to define AT(N) in Alzheimer disease

Niklas Mattsson-Carlgren et al.

NEUROLOGY (2020)

Article Clinical Neurology

Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study

Scott Ayton et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Neurosciences

Postmortem T2* - Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease

Marjolein Bulk et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Neurosciences

Cortical Iron Reflects Severity of Alzheimer's Disease

Sara van Duijn et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Clinical Neurology

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease

Panagiotis Alexopoulos et al.

ALZHEIMERS RESEARCH & THERAPY (2016)

Article Multidisciplinary Sciences

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment

J. M. G. van Bergen et al.

SCIENTIFIC REPORTS (2016)

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Article Multidisciplinary Sciences

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Scott Ayton et al.

NATURE COMMUNICATIONS (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects

Andrea Varrone et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

Article Clinical Neurology

CSF Apo-E levels associate with cognitive decline and MRI changes

Jon B. Toledo et al.

ACTA NEUROPATHOLOGICA (2014)

Article Geriatrics & Gerontology

Microglial activation in Alzheimer's disease: an (R)-[C-11]PK11195 positron emission tomography study

Alie Schuitemaker et al.

NEUROBIOLOGY OF AGING (2013)

Article Biochemistry & Molecular Biology

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Peng Lei et al.

NATURE MEDICINE (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease

Masamichi Yokokura et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Review Nutrition & Dietetics

Iron Homeostasis and the Inflammatory Response

Marianne Wessling-Resnick

ANNUAL REVIEW OF NUTRITION, VOL 30 (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Novel reference region model reveals increased microglial and reduced vascular binding of 11C(R)-PK11195 in patients with Alzheimer's disease

Giampaolo Tomasi et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Medicine, General & Internal

In-vivo measurement of activated microglia in dementia

A Cagnin et al.

LANCET (2001)